Corrigendum to "CA19-9, CEA and PIVKA-II as a novel panel of serum markers for diagnosis of pancreatic cancer" [Clin. Biochem. 137 (2025) 110902].

IF 2.1 3区医学 Q2 MEDICAL LABORATORY TECHNOLOGY

Clinical biochemistry Pub Date : 2025-09-30 DOI:10.1016/j.clinbiochem.2025.111017

Meifang Wang, Hongying Bu, Weijia Luo, Xi Zeng, Guodong Chen, Yingchun He, Deliang Cao

引用次数: 0

查看原文本刊更多论文

“CA19-9、CEA和PIVKA-II作为诊断胰腺癌的一组新的血清标志物”的勘误表[临床。生物化学，137(2025):110902。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical biochemistry 医学-医学实验技术

CiteScore

5.10

自引率

0.00%

发文量

151

审稿时长

25 days

期刊介绍： Clinical Biochemistry publishes articles relating to clinical chemistry, molecular biology and genetics, therapeutic drug monitoring and toxicology, laboratory immunology and laboratory medicine in general, with the focus on analytical and clinical investigation of laboratory tests in humans used for diagnosis, prognosis, treatment and therapy, and monitoring of disease.